Postoperative Radiotherapy for Uterine Cervical Cancer: Impact of Lymph Node and Histological Type on Survival
- GORO KASUYA1⇑,
- KAZUHIKO OGAWA2,
- SHIRO IRAHA3,
- YUTAKA NAGAI4,
- MAKOTO HIRAKAWA4,
- TAKAFUMI TOITA1,
- YASUMASA KAKINOHANA1,
- WATARU KUDAKA4,
- MORIHIKO INAMINE4,
- TAKURO ARIGA1,
- YOICHI AOKI4 and
- SADAYUKI MURAYAMA1
- 1Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, Okinawa, Japan
- 2Department of Radiation Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan
- 3Department of Radiology, Prefectural Nanbu Medical Center, Okinawa, Japan
- 4Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus, Okinawa, Japan
- Correspondence to: Dr. Goro Kasuya, Department of Radiology, Graduate School of Medical Science University of the Ryukyus School of Medicine, 207 Uehara, Nishihara-cho, Okinawa, 903-0215, Japan. Tel: +81 988953331 ext. 2401, Fax: +81 988951420, e-mail: gokasuya{at}gmail.com
Abstract
Aim: To retrospectively analyze the treatment results of postoperative radiotherapy (PORT) in patients with early-stage uterine cervical cancer. Patients and Methods: Records of 141 patients with stage IB-IIB uterine cervical cancer treated with PORT from 1985 to 2004 were retrospectively reviewed. The majority of patients received whole-pelvic radiotherapy with antero-posterior fields, and the total radiation doses ranged from 10.8-60 Gy (median: 50.4 Gy). The median follow-up of all 141 patients was 106 months (range: 0.8-273.7 months). Results: Multivariate analysis revealed that positive lymph node status (p=0.001) and histological type (p=0.015) were independent prognostic factors for overall survival. The group with three or more involved lymph nodes was significantly more likely to have extra-pelvic recurrence when compared with the groups with no (p=0.006) and up to two lymph nodes (p=0.024), respectively. Conclusion: PORT yielded excellent pelvic control rates for early-stage uterine cervical cancer. Lymph node status and histological type were significant prognostic factors for overall survival of patients with these tumors.
- Received March 13, 2013.
- Revision received April 16, 2013.
- Accepted April 17, 2013.
- Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved







